Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
Benzinga·2025-09-03 17:28Wave Life Sciences Ltd. WVE stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.WVE is encountering selling pressure. Review the technical setup here.Alpha-1 antitrypsin (AAT) deficiency is an inherited genetic disorder that reduces the production of the AAT protein, which is crucial for protecting the lungs and liver.Also Read: Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Dru ...